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a b s t r a c t
Acyclovir has been conjugated to the acyclic isoprenoid chain of squalene to form the
squalenoyl–acyclovir prodrug. Its interaction with biomembrane models constituted by dimyristoylphos-
phatidylcholine (DMPC) monolayers has been studied by employing the Langmuir–Blodgett technique.






DMPC/acyclovir or squalenoyl–acyclovir prodrug mixed monolayers have been prepared at increasing
molar fractions of the compound and the isotherm mean molecular area/surface pressure has been reg-




Acyclovir [9-(2-hydroxyethoxymethyl)guanine] is a potent and
ighly selective inhibitor of the replication of herpes viruses includ-
ng herpes simplex virus type 1 (HSV-I) and type 2 (HSV-2),
aricella-zoster virus, and Epstein-Barr virus both in cell cultures
nd in animals. It is currently used as a therapeutic agent for
he treatment of these viruses’ infections (O’Brien and Campoli-
ichards, 1989; Wagstaff et al., 1994; Kim et al., 1998; Périgaud
t al., 1999). To exert its action acyclovir has to cross the cellu-
ar membrane and reach the intracellular compartment where the
iruses are hosted. A useful approach to improve this transfer pro-
ess could be the use of a lipophilic membrane soluble prodrug of
cyclovir, and/or the inclusion of the prodrug into a carrier prepa-
ation such as liposomes. Then, the knowledge of the interaction
etween this prodrug and the biological membrane should be of
reat importance.
The lipid membranes are of highly complex structures, hence
heir biophysical interactions with drugs are difficult to investigate.
implified artificial membranes systems mimicking the natural
ipid membranes have been developed and used to study these
nteractions. Among the various models of cell membranes, lipid
angmuir monolayers are extensively used because several param-
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eters, such as lipid composition, subphase properties, pH and
temperature can be chosen to imitate real biological conditions
(Kaganer et al., 1999; Brezesinski and Möhwald, 2003; Gaboriaud
et al., 2005). Moreover, Langmuir monolayers offer the possibil-
ity of controlling the molecular organization in a bi-dimensional
structure similar to that of the biological membranes (Maget-Dana,
1999; Dynarowicz-Latka et al., 2001). By the film-balance method
the surface pressure/mean molecular area (/Å2) isotherm curves
are easily obtained. The phospholipids are spread on an aqueous
subphase to permit a monomolecular distribution. If the monolayer
is subjected to an area compression, the molecules distribution is
modified and the molecules are forced to go from a “gaseous” or
“liquid expanded” phase at low density to a “liquid condensed”
phase at a higher density and, successively, to a “solid condensed”
phase (Gaines, 1966; Mohwald, 1990; Prieto et al., 1998; Krasteva
et al., 2000; Vollhardt and Fainerman, 2000; Broniec et al., 2007).
Eventual variations in the behavior of the isotherms of the pure
phospholipid, caused by the presence of a compound dispersed
among the phospholipids on the aqueous surface can indicate
anomalies in the perfect miscibility of the phospholipid/compound
mixtures.
In previous studies of some of us, this technique was applied
to define the localization of lipophilic prodrugs of gemcitabine
(Stella et al., 2004/2005) in phospholipids monolayers (Castelli
et al., 2007a,b). In the present study, the interaction between a
lipophilic acyclovir prodrug (squalenoyl–acyclovir), obtained by
conjugation of acyclovir with the squalene acyclic isoprenoid chain






















Scheme 1. Acyclovir, squaleneCOOH and squalenoyl–acyclovir structure.
squaleneCOOH) (Scheme 1), and dimyristoylphosphatidylcholine
DMPC) in mixed monolayers was explored. To have more infor-
ation, the interaction of the non-conjugate compounds (acyclovir
nd squaleneCOOH) with DMPC was also investigated. Results per-
it to obtain indication on the ability of the examined compounds
o dissolve, or not, in the phospholipid molecules that form the
onolayer and then to have indication on their interaction with
hospholipids membranes.
. Materials and methods
.1. Materials
Acyclovir (purity ≥ 99%) and squalene (purity = 98%) were
urchased from Sigma–Aldrich (Italy). 1,1′,2-Tris-nor-squalene
ldehyde was obtained from squalene as previously described
Ceruti et al., 2005). Synthetic l--dimyristoylphosphatidylcholine
DMPC) (purity ≥ 98%) was obtained from Genzyme (Switzer-
and). Lipids were chromatographically pure as assessed by
wo-dimensional thin layer chromatography.
.2. Synthesis of the compounds.2.1. 1,1′,2-Tris-nor-squalene acid: (4E,8E,12E,16E)-
,8,13,17,21-pentamethyl-4,8,12,16,20-docosapentaenoic
cid
1,1′,2-Tris-nor-squalene aldehyde (1.58 g, 4.11 mmol) was dis-
olved in diethyl ether (20 ml) at 0 ◦C. Separately, sulfuric acidf Pharmaceutics 395 (2010) 167–173
(2.3 ml) was added at 0 ◦C to distilled water (20 ml) with stir-
ring, followed by potassium dichromate (1.21 g, 4.11 mmol) to
obtain chromic acid. It was then added at 0 ◦C within 20 min to
the solution of the aldehyde previously prepared and left to react
for 2 h at 0 ◦C with stirring. The reaction mixture was extracted
with diethyl ether (50 ml 3×), washed with saturated brine, dried
over anhydrous sodium sulfate and evaporated in vacuo. The com-
pletion of the reaction was revealed by silica gel TLC with light
petroleum/diethyl ether/methanol, 70:23:7. The crude product was
purified by flash chromatography with light petroleum, then light
petroleum/diethyl ether, 95:5 as eluant, to give 577 mg of 1,1′,2-
tris-nor-squalene acid (35% yield), as a colourless oil. 1H NMR
(CDCl3): ı, 1.55–1.63 (m, 18H, allylic CH3), 1.90–2.05 (m, 16H,
allylic CH2), 2.26 (t, 2H, CH2CH2COOH), 2.38 (t, 2H, CH2CH2COOH),
5.00–5.19 (m, 5H, vinylic CH), 12.20 (broad, 1H, COOH). MS (EI):




1,1′,2-Tris-nor-squalene acid (178 mg, 0.444 mmol) was dis-
solved in anhydrous DMF (1.5 ml) in a three-necked flask under
nitrogen, with stirring, at room temperature, followed by dimethy-
laminopiridine chloridrate (DMAP) (×2.2; 120 mg, 0.98 mmol) in
anhydrous DMF (1.5 ml). Acyclovir (100 mg, 0.444 mmol) was dis-
solved in anhydrous DMF (2 ml), with soft heating and slowly added
to the previously prepared solution heated at 60 ◦C in a silicon
bath, with stirring. When the reaction mixture resulted homoge-
neous, N-(3-dimethylaminopropyl)-N′-ethylcarbodiimide (EDCA)
(×2.2; 188 mg, 0.98 mmol), dissolved in anhydrous DMF (1.5 ml)
was added and allowed to react for 3 days, with stirring, under
nitrogen, at 70 ◦C. The reaction mixture was controlled by silica gel
TLC with ethanol/chloroform/cyclohexane, 50:25:25, transferred in
a one-necked flask and evaporated to dryness. The crude deriva-
tive was dissolved in dichloromethane, washed with a 3% aqueous
HCl solution, washed with saturated brine until neutral pH, dried
over anhydrous sodium sulfate and evaporated in vacuo. The crude
product was purified by silica gel flash chromatography previously
eluded alone with dichloromethane/triethylamine, 99:1 and neu-
tralized with dicloromethane. The elution of the crude product was
performed with dichloromethane/ethanol, 95:5 to give 115 mg of
squalenoyl–acyclovir (42% yield), as a pale yellow viscous oil. It
was completely pure, as revealed by 1H NMR and mass analysis.
Concerning the possibility of obtaining either an ester or an amide
linkage between the squalenoyl chain and acyclovir, 1H NMR anal-
ysis revealed the presence of the free amino group at 6.57 ı (2H, s,
NH2), while the signal at about 12 ı of the hypothetic amidic group
was completely absent. It was also confirmed by comparison of
1H NMR spectra of ester and amide acetyl derivatives of acyclovir
reported in literature (Matsumoto et al., 1987). 1H NMR (DMSO): ı,
1.52–1.65 (18H, m, allylic CH3), 1.94–2.10 (16H, m, allylic CH2), 2.13
(2H, t, OCOCH2CH2), 2.31 (2H, t, OCOCH2), 3.63 (2H, m, 3′-OCH2),
4.06 (2H, m, 4′-CH2OCO), 5.03–5.25 (5H, m, vinylic CH), 5.32 (2H,
s, 1′-NCH2O), 6.57 (2H, s, NH2), 7.78 (1H, s, 8-CH), 10.69 (1H, s,
1-NHCO). MS (CI): m/z 608 (M+, 100).
2.3. Surface tension measurements
Film-balance measurements were performed using a KSV mini-
trough apparatus provided with a computer interface unit and
an operating software. The trough (24,225 mm2 available area)
made in Teflon was connected to a circulating water bath to
keep the temperature constant. 5 mM Tris (pH = 7.4) in ultra-
pure Millipore water with resistivity of 18.2 M cm was used
as subphase. Equimolar solutions (0.001 mmol/ml) of DMPC,
squaleneCOOH, squalenoyl–acyclovir and acyclovir in organic sol-
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ents were prepared. Mixed DMPC/compound solutions were
uccessively prepared to obtain the following molar fractions for
ach compound: 0.015, 0.03, 0.045, 0.06, 0.09, 0.12, 0.25, 0.50, and
.75. 30 l of the mixed solutions as well as the pure components
ere spread drop-by-drop on the surface of the subphase by a
amilton microsyringe (which, before use, was cleaned three times
ith chloroform and the examined solution) and, after waiting
5 min for solvent evaporation, the monolayers were compressed
y the use of two mobile barriers made in Delrin at the constant
peed of 10 mm/min. Surface pressure vs. molecular area isotherms
ere recorded by the Wilhelmy plate arrangement attached to
microbalance. Before spreading the sample, the subphase was
hecked twice by running blank experiments to be sure that no
mpurities were present. The experiments were performed at a sub-
hase temperature of 10 and 37 ◦C. Each experiment was repeated
t least three times to be sure of the reproducibility of the isotherm
easurements.
.4. Surface pressure/molecular area isotherms analysis
.4.1. Monolayer miscibility
The surface pressure/molecular area isotherms were analyzed
y calculating, at different surface pressures, the molecular area
s a function of the monolayer composition (expressed in molar
raction). The averaged molecular area of a two-components mono-
ayer can be calculated by A = A1X1 + (1 − X1) A2, where A is the mean
olecular area, X1 is the molar fraction of component 1, X2 = 1 − X1,
nd A1 and A2 are the areas per molecule of the monolayer pure
omponents at the same surface pressure. When the two compo-
ents are either ideally miscible or completely immiscible at the
ir/liquid interface, reporting in a graph A as a function of X1, a
traight line is obtained (Gaines, 1966; Shahgaldian and Coleman,
003). Any deviation from the straight line indicates that the mis-
ibility of the components is non-ideal.
.4.2. Monolayer stability
A convenient and powerful tool to evaluate mixed monolayer
tability is excess Gibb’s energy (Gex). In case of ideal mixing
etween monolayer components, where one component is com-
letely mixed with the other monolayer component, Gex attains
value. Similarly, the presence of repulsive interactions between
onolayer components results in a positive Gibb’s excess, while
ssociative or attractive interactions result in a negative Gibb’s
xcess (Chou and Chang, 2000). Excess free energy of mixing
as calculated by applying the equation: Gex
∫ 
0
[A12 − (X1A1 +
2A2)] d; where X1 and X2 are the molar fractions of the two com-
onents, while A1 and A2 are the molar areas of the monolayer
ure components; A12 is the effective molar area occupied by the
ixed monolayer and  is the surface pressure. Positive Gibb’s
xcess is suggestive of the formation of thermodynamically unsta-
le monolayers, while a negative Gibb’s excess indicates stable
ystems (Chimote and Banerjee, 2008).
. Results and discussion
.1. Molecular area/surface pressure isotherms
Mixed monolayers of DMPC/acyclovir, DMPC/squaleneCOOH
nd DMPC/squalenoyl–acyclovir at the air/water interface have
een prepared and their behavior has been studied and com-
ared with that of single component monolayers. The molecular
rea/surface pressure isotherms have been recorded at 10 ◦C
Fig. 1A–C) and 37 ◦C (Fig. 2A–C), below and above the pure phos-
holipid transition temperature.
10 ◦C measurements. When distributed as a monolayer,
olecules exist in different states, depending upon surface pres-Fig. 1. Surface pressure/molecular area isotherms of DMPC and (A) acyclovir, (B)
squaleneCOOH and (C) squalenoyl–acyclovir mixed monolayers at the air–water
interface at 10 ◦C.
sure and temperature. At low pressure, the DMPC monolayer is in a
gaseous-like phase (the surface area per molecule ranging from 120
to about 100 Å2) with the acyl chains most apart in the air. Further
compression forces the monolayer into the liquid expanded (LE)
phase (area between 100 and 65 Å2); then the monolayer is sub-
jected to a liquid-expanded–liquid-condensed (LE–LC) transition
(area from about 65 to 45 Å2). Finally, a further compression yields
a liquid condensed (LC) phase (area lower than 45 Å2) producing a
steep rise in the surface tension.
Acyclovir does not form monolayers, but its presence, at molar
fraction higher than 0.09, causes the isotherms to gradually move
towards lower molecular areas and the LE–LC transition tempera-
ture to gradually decrease (Fig. 1A). SqualeneCOOH is in a gaseous
state in the range of 120–85 Å2, and in a LE state at areas smaller
than 85 Å2. This compound, at low molar fraction, does not cause


















temperature, acyclovir does not show any isotherm. Up to 0.03 M
fraction, acyclovir causes the isotherm to move towards higher
molecular area, but at higher molar fraction, it causes the isotherm
to move towards lower molecular area (Fig. 2A). SqualeneCOOH isig. 2. Surface pressure/molecular area isotherms of DMPC and (A) acyclovir, (B)
qualeneCOOH and (C) squalenoyl–acyclovir mixed monolayers at the air–water
nterface at 37 ◦C.
ignificant variations of the isotherm: at 0.25 M fraction the LE–LC
ransition disappears and the isotherm moves towards higher
alue of the molecular area; higher squaleneCOOH molar fractions
ause the isotherms to shift towards lower molecular area values
Fig. 1B).
Squalenoyl–acyclovir is characterized by a gaseous phase from
20 to 65 Å2, a LE phase from 65 to about 35 Å2, a LE–LC transi-
ion from about 35 to 10 Å2, and then a LC phase. The presence
f squalenoyl–acyclovir, up to 0.09 M fraction, does not determine
ubstantial variations of the DMPC isotherms, just a small shift
owards higher molecular areas; at 0.12 M fraction, the isotherms
ose the LE–LC transition, although their shape remains almost
nchanged. As the squalenoyl–acyclovir molar fraction further
ncreases, the isotherms move towards lower molecular areas and
xhibit a well-defined transition (Fig. 1C).f Pharmaceutics 395 (2010) 167–173
37 ◦C measurements. DMPC shows two regions: a gaseous phase
from 120 to 110 Å2 and a LE region starting from 110 Å2. Even at thisFig. 3. Molecular area of the mixed monolayers of DMPC and (A) acyclovir, (B)
squaleneCOOH and (C) squalenoyl–acyclovir at the air–water interface plotted as




















The mean molecular area of the mixed monolayers has been
reported as a function of compound molar fraction at 10, 20 and
30 mN/m (Figs. 3A–C and 4A–C).M.G. Sarpietro et al. / International Jou
n a gaseous state at molecular areas between 120 and 60 Å2, and
n a LE state at lower areas. The increase of squaleneCOOH molar
raction in DMPC monolayers determines the isotherm to gradually
hift towards smaller areas (Fig. 2B). Even at 37 ◦C, as the com-
ression increases, squalenoyl–acyclovir presents four regions: a
aseous phase from 120 to 60 Å2, a LE phase from 60 to about
0 Å2, a LE–LC transition from about 30 to 15 Å2, and a LC phase
or smaller molecular areas. No significant variations are noted in
he isotherms with squalenoyl–acyclovir up to 0.12 M fraction; at
igher molar fractions, squalenoyl–acyclovir, causes the isotherms
o shift towards lower molecular areas and the LE–LC transition to
ppear and became more evident (Fig. 2C)
ig. 4. Molecular area of the mixed monolayers of DMPC and (A) acyclovir, (B)
qualeneCOOH and (C) squalenoyl–acyclovir at the air–water interface plotted as
function of the molar fraction of compound at various values of surface pressures
t 37 ◦C.f Pharmaceutics 395 (2010) 167–173 171
3.2. Surface pressure/molecular area isotherms analysisFig. 5. Excess Gibb’s free energies of mixing in DMPC and (A) acyclovir, (B)
squaleneCOOH and (C) squalenoyl–acyclovir mixed monolayer as a function of the











72 M.G. Sarpietro et al. / International Jou
10 ◦C measurements. With regard to acyclovir/DMPC mixed
onolayers (Fig. 3B), at low molar fraction of acyclovir, the exper-
mental values almost coincide with the ideal values, suggesting
ood miscibility between acyclovir and DMPC; at high acyclovir
olar fraction, a positive deviation is found, suggesting the
ormation of a non-ideal monolayer with dominant repulsive inter-
ctions. In squaleneCOOH/DMPC mixed monolayers (Fig. 3B), at low
ig. 6. Excess Gibb’s free energies of mixing in DMPC and (A) acyclovir, (B)
qualeneCOOH and (C) squalenoyl–acyclovir mixed monolayer as a function of the
olar fraction of compound at various values of surface pressures at 37 ◦C.f Pharmaceutics 395 (2010) 167–173
squaleneCOOH molar fractions, the experimental values overlap
the ideal behavior, suggesting a complete and the ideal miscibility
between the monolayer components. At high squaleneCOOH molar
fractions, positive deviations are present indicating that repulsive
interactions occur among squaleneCOOH and DMPC molecules. The
behavior of squalenoyl–acyclovir/DMPC mixed monolayers pos-
itively deviate from the ideality at all the squalenoyl–acyclovir
molar fractions and surface pressures, suggesting repulsive inter-
actions between the monolayer components (Fig. 3C).
37 ◦C measurements. Positive deviations, and hence repulsive
interactions, are observed in acyclovir/DMPC mixed monolayers
for all the acyclovir molar fractions and surface pressures, partic-
ularly at 20 mN/m (Fig. 4A). Increasing the squaleneCOOH molar
fraction, the squaleneCOOH/DMPC mixed monolayers exhibit first
negative deviations, then, positive deviations for all the consid-
ered surface pressures. It suggests the formation of immiscible
monolayers where attractive and repulsive interactions occur at
low and high squaleneCOOH molar fraction, respectively (Fig. 4B).
Squalenoyl–acyclovir mixed monolayers, up to 0.045 M fraction of
squalenoyl–acyclovir, show an ideal behavior. On increasing the
squalenoyl–acyclovir molar fraction, especially at 20 mN/m, the
occurrence of positive deviations is suggestive of repulsive forces
between DMPC and squalenoyl–acyclovir (Fig. 4C).
3.2.2. Monolayer stability
10 ◦C measurements. The behavior of Gex against the acyclovir
molar fraction is shown in Fig. 5A. On increasing the acyclovir
concentration, negative and positive deviations of Gex alter-
nate, suggesting stabilization and de-stabilization of the monolayer
with acyclovir concentration. With regard to squaleneCOOH
(Fig. 5B), generally positive deviations are found, indicating the
formation of squaleneCOOH/DMPC unstable monolayers. In the
case of squalenoyl–acyclovir (Fig. 5C), at all prodrug molar
fractions, positive deviations are present suggesting unstable
squalenoyl–acyclovir/DMPC monolayers.
37 ◦C measurements. Acyclovir (Fig. 6A) causes positive devi-
ation in the acyclovir/DMPC monolayer, especially at low molar
fractions, leading to the formation of unstable monolayers. At low
molar fraction, squaleneCOOH (Fig. 6B) causes negative deviations,
becoming positive at high molar fractions. This suggests that at
low molar fraction of compound, a stable monolayer exists, which
becomes unstable by increasing the squaleneCOOH molar fraction.
In the squalenoyl–acyclovir/DMPC monolayers (Fig. 6C), the exper-
imental values overlap the ideal values at very low molar fractions
of squalenoyl–acyclovir, then strong positive deviations (unstable
monolayers) are observed.
4. Conclusion
The lipophilic squalenoyl–acyclovir prodrug was obtained by
conjugation of acyclovir with the squalene acyclic isoprenoid chain.
The behavior of the prodrug, acyclovir and squaleneCOOH in the
monolayer at the air/water interface and their interaction with a
biomembrane model made up of dimyristoylphosphatidylcholine
monolayers was studied. The above reported Langmuir–Blodgett
measurements give information not obtainable by other tech-
niques, evidencing that the squaleneCOOH group confers to the
prodrug a behavior quite different than that shown by acyclovir.
In particular, acyclovir does not form any monolayer, while the
prodrug forms a stable monolayer which evidence a characteris-
tic phase transition upon compression. This transition is preserved
in DMPC/squalenoyl–acyclovir mixed monolayers at high prodrug
molar fractions. All the studied compounds interact with DMPC,
as also reported in previous studies carried out by differential
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t al., 2009). The different effect of the investigated compounds
n DMPC monolayer is considerably influenced by the presence
f the squalenoyl group bound to acyclovir which modifies the
hape of the isotherms. These effects are much more evident than
hose previously observed by calorimetry (Sarpietro et al., 2009).
n particular, the positive deviations of both the surface area excess
Figs. 3 and 4) and the Gibb’s free energy excess (Figs. 5 and 6)
learly indicate repulsive interactions between the monolayer
omponents. Furthermore, the comparison of all the above results
ay provide information on the localization of the three com-
ounds in DMPC monolayers. Acyclovir produces a small expansion
ffect, probably because it is localized near the DMPC polar heads
nd do not contribute to the hydrophobic interactions among the
hospholipid chains. SqualeneCOOH could be localized parallel
o the phospholipids chain with the carboxylic group protruding
owards the subphase. The increase of the lipophilic character of
cyclovir through its conjugation to squaleneCOOH and the forma-
ion of the squalenoyl–acyclovir prodrug gives rise to a stronger
nteraction with DMPC monolayer with respect to those of the free
rug. This effect probably arises because the prodrug molecules is
nserted among the DMPC acylic chain in a way that the phospho-
ipids molecules are forced to occupy a larger area. Almost the ideal
ehavior observed at 37 ◦C and at low molar fraction could depend
n the flexibility of the molecule at this temperature, which well
dapts to the surrounding phospholipid chains.
cknowledgments
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